All News Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 09:02:43 29/04/2024 BST			5-day change	1st Jan Change
885.4 ^DKK	-0.14%		+1.65%	+27.45%

04-25	NOVO NORDISK : JP Morgan gives a Buy rating	ZD
04-25	Scholz promises support for pharma sector in Germany as Merck invests	RE

Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period \| Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals	04-26	AQ
NOVO NORDISK : JP Morgan gives a Buy rating	04-25	ZD
Scholz promises support for pharma sector in Germany as Merck invests	04-25	RE
Sector Update: Health Care Stocks Slipping Late Afternoon	04-24	MT
Sector Update: Health Care	04-24	MT
Novo Nordisk's Wegovy FDA Approval for Heart Health Opens Door to Medicare Access, KKF Says	04-24	MT
US Senate committee investigates pricing of Novo's Ozempic and Wegovy	04-24	RE
Novo Nordisk Probed by Senate Committee on Weight-Loss Drug Prices	04-24	DJ
Novo Nordisk A/S : Reduction of the share capital	04-24	PU
Novo Nordisk A/S - Articles of Association, April 2024	04-24	GL
Novo Nordisk A/S – Reduction of the share capital	04-24	GL
NOVO NORDISK : Bernstein maintains a Buy rating	04-24	ZD
Germany's Evotec appoints Christian Wojczewski as CEO	04-23	RE
UK stocks may finally be back in fashion	04-23	RE
Health Care Climbs on Earnings Hopes -- Health Care Roundup	04-22	DJ
Eli Lilly to acquire manufacturing facility from Nexus Pharma	04-22	RE
Novo Nordisk A/S - share repurchase programme	04-22	GL
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut	04-21	AQ
India's Biocon developing its own version of Wegovy, clinical trial likely next year	04-18	RE
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	04-15	GL